Derivatives of these compounds include epirubicin and idarubicin.
这些化合物的衍生物包括表柔比星和伊达比星。
Objective To study the distribution of epirubicin in blood and pancreatic tissue of rats.
陶蔚目的研究表阿霉素在大鼠胰腺和血液中的分布规律。
OBJECTIVE To study the stability and in vitro cytotoxicity of two kinds of dextran-epirubicin conjugates.
目的研究两种方法制备的葡聚糖-表柔比星偶合物的稳定性及体外细胞毒活性。
ABSTRACT: OBJECTIVE To study the stability and in vitro cytotoxicity of two kinds of dextran-epirubicin conjugates .
目的研究两种方法制备的葡聚糖-表柔比星偶合物的稳定性及体外细胞毒活性。
Objective To investigate the inhibition of 7 human cancer cell lines by resveratrol and epirubicin treated in combination.
目的探讨白藜芦醇与表阿霉素联合用药对7种人类肿瘤细胞的抑制作用。
This class of agents includes doxorubicin, daunorubicin, and epirubicin, which are often used as adjuvant therapy in breast cancer.
这剂类包括阿霉素，柔红霉素，阿霉素和，这些问题往往在乳腺癌辅助疗法。
Results: the peak and the mean levels of epirubicin in the peritoneal fluid were 228 and 167 times higher than the corresponding peripheral vein levels.
结果表阿霉素在术后早期腹腔内化疗时腹腔液峰值浓度比外周静脉高228倍，且持续时间长；腹腔液总平均浓度比外周静脉高167倍。
Objective:To observe the efficacy and toxicity of domestic epirubicin in treatment of non Hodgkin's lymphoma, breast cancer, and non small cell lung cancer.
目的：观察国产表柔比星为主的联合化疗方案治疗非霍奇金淋巴瘤、乳腺癌、非小细胞肺癌的疗效和不良反应。
Objective To explore the clinical curative effect of Shenfu Injection combined with epirubicin and paclitaxel in treatment of triple negative breast cancer.
目的：探究参附注射液联合表柔比星和紫杉醇治疗三阴性乳腺癌的临床疗效。
The results show that epirubicin chemotherapy regimens were effective and were suitable to the patients with heart failure or abnormal electrocardiogram(ECG).
毒性观察显示，表阿霉素为主方案的骨髓和消化道毒性低，心脏损害轻，适于伴心功不全或心电图异常患者使用。
Objective To evaluate the left ventricular myocardial regional systolic and diastolic function of Epirubicin-induced cardiotoxicity using strain rate imaging(SRI).
目的探讨应变率成像技术评价乳腺癌术后患者表阿霉素复合药物心脏毒性对左室心肌局部收缩及舒张功能影响价值。
Purpose: To study the short-term efficacy and toxicity of the neoajuvant chemotherapy with epirubicin (EPI) plus paclitaxel( TAX) in treatment of patients with breast cancer.
目的：研究表柔比星加紫杉醇新辅助化疗方案治疗乳腺癌的近期疗效及毒副反应。
Objective to evaluate the treatment of non-Hodgkin s lymphoma with combined regimen containing epirubicin as the main drug and to find an effective regimen with low toxicity.
目的评估表柔比星为主的联合方案治疗非霍奇金淋巴瘤的疗效。
Objectives: To prepare epirubicin hydrochloride liposomes(Epi-lip), establish an HPLC method for the determination of EPI and to optimize the method for determination of entrapment efficiency(EE%).
目的：制备盐酸表阿霉素脂质体，建立HPLC含量测定方法并优选包封率测定方法。
The silicagel column has showed an irreversible adsorption equilibrium for epirubicin and its analogues with slightly acidic or neutral mobile phases in hydrophilic interaction chromatography (HILIC).
亲水作用色谱分离表阿霉素时，在中性及弱酸性条件下，样品在硅胶柱上呈现不可逆吸附平衡过程。
The silicagel column has showed an irreversible adsorption equilibrium for epirubicin and its analogues with slightly acidic or neutral mobile phases in hydrophilic interaction chromatography (HILIC).
亲水作用色谱分离表阿霉素时，在中性及弱酸性条件下，样品在硅胶柱上呈现不可逆吸附平衡过程。
应用推荐